Skip to main content
Clinical Trials/NCT01632813
NCT01632813
Completed
N/A

Neurocognitive Development in Children With Congenital Heart Disease: Growing Into Deficit

KU Leuven1 site in 1 country172 target enrollmentJuly 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Heart Defects, Congenital
Sponsor
KU Leuven
Enrollment
172
Locations
1
Primary Endpoint
reaction time (RT) and error rates of inhibitory control (Response Organization Objects, ROO) (Amsterdam Neuropsychological Tasks, ANT)
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The key objective of the Leuven growing-into-deficit (GID) follow-up-study is to test the hypothesis that children with a congenital heart disease (CHD) show more neurocognitive impairment at the second follow-up at 7 years old than at the first follow-up at the age of 4, compared to healthy controls.

Registry
clinicaltrials.gov
Start Date
July 2012
End Date
September 2014
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
KU Leuven
Responsible Party
Principal Investigator
Principal Investigator

Greet Van den Berghe

Head of Dept Intensive Care Medicine

KU Leuven

Eligibility Criteria

Inclusion Criteria

  • Seven-year-old children with CHD and healthy control children who were four years old when they participated in Paediatric ICU follow-up study (i.e. first follow-up time point) (Neurocognitive development of children four years after critical illness and treatment with tight glucose control, Clinical Trials # NCT00214916). The children of the CHD-group underwent cardiac surgery as infants (=\<1year).

Exclusion Criteria

  • Genetic syndromes (Down, 22q11del), known to result in neurocognitive impairment
  • Lack of baseline neurocognitive measurements during first follow-up
  • Date of birth before February 2005

Outcomes

Primary Outcomes

reaction time (RT) and error rates of inhibitory control (Response Organization Objects, ROO) (Amsterdam Neuropsychological Tasks, ANT)

Time Frame: one testpoint at age of 7 years

Secondary Outcomes

  • Number of taps on computerized tapping tasks (ANT)(one testpoint at age of 7 years)
  • IQ measures (Revised Wechsler Preschool and Primary Scale of Intelligence, WPPSI-R)(one testpoint at age of 7 years)
  • Visual-Motor Integration total standard score (VMI)(one testpoint at age of 7 years)
  • Child Behavior CheckList T-scores for internalizing and externalizing problems(one testpoint at age of 7 years)
  • Pediatric Quality of Life Inventory - Generic Score Scales (PedsQL) to quantify quality of life(one testpoint at age of 7 years)
  • reaction time (RT) and error rates of cognitive flexibility (ROO, ANT) and working memory (Memory Search - Objects 2 Keys, ANT)(one testpoint at age of 7 years)
  • Mean RT + standard deviation (SD) of RT on computerized alertness task (Baseline Speed, ANT)(one testpoint at age of 7 years)
  • Behavior Rating Inventory of Executive Function (BRIEF) to measure executive functions (parent and teacher version)(one testpoint at age of 7 years)
  • Teacher Report Form (TRF) T-scores for internalizing and externalizing problems at school(one testpoint at age of 7 years)
  • Incidence of medical problems (e.g. head trauma), interventions and operations since first follow-up(one testpoint at age of 7 years)

Study Sites (1)

Loading locations...

Similar Trials